Skip to main content
. 2021 Dec 16;26(50):2001559. doi: 10.2807/1560-7917.ES.2021.26.50.2001559

Figure 4.

Adjusted SARS-CoV-2 IgG antibody seroprevalence by region, Ontario, Canada, 5–30 June 2020 (n = 7,014)a

CI: confidence interval; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

a Population in each region [15]: Northern (n = 796,974); Eastern (n = 1,926,380); Central East (n = 4,480,654); Toronto (n = 3,120,358); Central West (n = 2,849,288); South West (n = 1,690,774).

Figure 4